{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:35:29Z","timestamp":1792193729362,"version":"4.4.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11912-024-01619-1","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T08:55:28Z","timestamp":1732697728000},"page":"1575-1585","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Breast cancer Treatment and Fertility Preservation: A Narrative Review of Impacts, Strategies and Ethical Considerations"],"prefix":"10.1007","volume":"26","author":[{"given":"Prakriti Anuj","family":"Sachdev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie George","family":"Ayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6167-4023","authenticated-orcid":false,"given":"Constantina","family":"Constantinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"issue":"11","key":"1619_CR1","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/cac2.12207","volume":"41","author":"S Lei","year":"2021","unstructured":"Lei S, Zheng R, Zhang S, et al. Global patterns of breast cancer incidence and mortality: a population-based cancer registry data analysis from 2000 to 2020. Cancer Commun (Lond). 2021;41(11):1183\u201394.","journal-title":"Cancer Commun (Lond)"},{"key":"1619_CR2","doi-asserted-by":"publisher","unstructured":"Llarena, N.C., Estevez, S.L., Tucker, S.L. and Jeruss, J.S., 2015. Impact of Fertility Concerns on Tamoxifen Initiation and Persistence. J Natl Cancer Inst 107(10), djv202. https:\/\/doi.org\/10.1093\/jnci\/djv202. Print 2015 Oct","DOI":"10.1093\/jnci\/djv202"},{"issue":"19","key":"1619_CR3","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1200\/JCO.2018.78.1914","volume":"36","author":"K Oktay","year":"2018","unstructured":"Oktay K, Harvey BE, Partridge AH, et al. Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol. 2018;36(19):1994\u20132001.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1619_CR4","first-page":"147","volume":"58","author":"P Vukovi\u0107","year":"2019","unstructured":"Vukovi\u0107 P, Kasum M, Ragu\u017e J, et al. Fertility preservation in young women with early-stage breast cancer. Acta Clin Croat. 2019;58(1):147\u201356.","journal-title":"Acta Clin Croat"},{"issue":"3","key":"1619_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.breast.2014.03.011","volume":"23","author":"AH Partridge","year":"2014","unstructured":"Partridge AH, Pagani O, Abulkair O, et al. First international consensus guidelines for breast cancer in young women (BCY1). Breast. 2014;23(3):209\u201320.","journal-title":"Breast"},{"key":"1619_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-015-0545-7","volume":"14","author":"M Lambertini","year":"2016","unstructured":"Lambertini M, Del Mastro L, Pescio MC, et al. Cancer and fertility preservation: international recommendations from an expert meeting. BMC Med. 2016;14:1\u20137.","journal-title":"BMC Med"},{"issue":"2","key":"1619_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.gendis.2018.05.001","volume":"5","author":"Y Feng","year":"2018","unstructured":"Feng Y, Spezia M, Huang S, et al. Breast cancer development and progression: risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis. 2018;5(2):77\u2013106.","journal-title":"Genes Dis"},{"key":"1619_CR8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/978-3-030-41596-9_24","volume-title":"Diseases of the Breast During Pregnancy and Lactation","author":"KD Dinas","year":"2020","unstructured":"Dinas KD. Impact of breast cancer treatment on fertility. In: Alipour S, Omranipour R, editors. Diseases of the Breast During Pregnancy and Lactation. Cham: Springer International Publishing; 2020. p. 175\u20139."},{"issue":"4","key":"1619_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.senol.2021.08.004","volume":"35","author":"C Castillo","year":"2022","unstructured":"Castillo C, Camejo N. Impact of breast cancer treatments on fertility and the importance of timing for a fertility preservation intervention. Rev Senol Patol Mam. 2022;35(4):305\u201311. https:\/\/doi.org\/10.1016\/j.senol.2021.08.004.","journal-title":"Rev Senol Patol Mam"},{"key":"1619_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2020.572388","volume":"11","author":"D Mauri","year":"2020","unstructured":"Mauri D, Gazouli I, Zarkavelis G, et al. Chemotherapy associated ovarian failure. Front Endocrinol. 2020;11:1\u201310.","journal-title":"Front Endocrinol"},{"issue":"1","key":"1619_CR11","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1186\/s12885-017-3593-x","volume":"17","author":"A Wenners","year":"2017","unstructured":"Wenners A, Grambach J, Koss J, et al. Reduced ovarian reserve in young early breast cancer patients: preliminary data from a prospective cohort trial. BMC Cancer. 2017;17(1):632.","journal-title":"BMC Cancer"},{"key":"1619_CR12","doi-asserted-by":"publisher","first-page":"117955811987249","DOI":"10.1177\/1179558119872490","volume":"13","author":"Z Blumenfeld","year":"2019","unstructured":"Blumenfeld Z. Fertility preservation in women with malignancy: future endeavors. Clin Med Insights Reprod Health. 2019;13:1179558119872490.","journal-title":"Clin Med Insights Reprod Health"},{"issue":"3","key":"1619_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.5152\/ejbh.2020.5114","volume":"16","author":"F \u00c7elebi","year":"2020","unstructured":"\u00c7elebi F, Ordu \u00c7, Ilg\u00fcn S, et al. The effect of systemic chemotherapy on ovarian function: a prospective clinical trial. Eur J Breast Health. 2020;16(3):177\u201382.","journal-title":"Eur J Breast Health"},{"key":"1619_CR14","unstructured":"National Cancer Institute. Hormone Therapy for Breast Cancer. July 12, 2022. Available from: https:\/\/www.cancer.gov\/types\/breast\/breast-hormone-therapy-fact-sheet"},{"issue":"4","key":"1619_CR15","first-page":"405","volume":"17","author":"A Tremont","year":"2017","unstructured":"Tremont A, Lu J, Cole JT. Endocrine therapy for early breast cancer: updated review. Ochsner J. 2017;17(4):405\u201311.","journal-title":"Ochsner J"},{"issue":"1","key":"1619_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.fertnstert.2016.10.020","volume":"107","author":"LM Shandley","year":"2017","unstructured":"Shandley LM, Spencer JB, Fothergill A, et al. Impact of tamoxifen therapy on fertility in breast cancer survivors. Fertil Steril. 2017;107(1):243-252.e5.","journal-title":"Fertil Steril"},{"key":"1619_CR17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ejca.2021.03.017","volume":"151","author":"HJ Kim","year":"2021","unstructured":"Kim HJ, Noh WC, Nam SJ, et al. Five-year changes in ovarian function restoration in premenopausal patients with breast cancer taking tamoxifen after chemotherapy: an ASTRRA study report. Eur J Cancer. 2021;151:190\u2013200.","journal-title":"Eur J Cancer"},{"key":"1619_CR18","unstructured":"National Breast Cancer Foundation. Targeted Therapy. January 17, 2024. Available from: https:\/\/www.nationalbreastcancer.org\/breast-cancer-targeted-therapy\/"},{"key":"1619_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/bs.adgen.2021.08.002","volume":"108","author":"P Mehta","year":"2021","unstructured":"Mehta P, Bothra SJ. PARP inhibitors in hereditary breast and ovarian cancer and other cancers: A review. Adv Genet. 2021;108:35\u201380.","journal-title":"Adv Genet"},{"key":"1619_CR20","doi-asserted-by":"publisher","first-page":"114028","DOI":"10.1016\/j.biopha.2022.114028","volume":"157","author":"J Li","year":"2023","unstructured":"Li J, Li Q, Zhang L, Zhang S, Dai Y. Poly-ADP-ribose polymerase (PARP) inhibitors and ovarian function. Biomed Pharmacother. 2023;157:114028.","journal-title":"Biomed Pharmacother"},{"issue":"20","key":"1619_CR21","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.3390\/cancers15204923","volume":"15","author":"G Scavone","year":"2023","unstructured":"Scavone G, Ottonello S, Blondeaux E, et al. The role of cyclin-dependent kinases (CDK) 4\/6 in the ovarian tissue and the possible effects of their exogenous inhibition. Cancers. 2023;15(20):4923. https:\/\/doi.org\/10.3390\/cancers15204923.","journal-title":"Cancers"},{"issue":"7","key":"1619_CR22","doi-asserted-by":"publisher","first-page":"119044","DOI":"10.1016\/j.bbamcr.2021.119044","volume":"1868","author":"F Dong","year":"2021","unstructured":"Dong F, Meng T, Li J, et al. Inhibition of CDK4\/6 kinases causes production of aneuploid oocytes by inactivating the spindle assembly checkpoint and accelerating first meiotic progression. Biochim Biophys Acta Mol Cell Res. 2021;1868(7):119044.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"1619_CR23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.reprotox.2019.07.016","volume":"88","author":"NR Catlin","year":"2019","unstructured":"Catlin NR, Bowman CJ, Engel SM, et al. Reproductive and developmental toxicity assessment of palbociclib, a CDK4\/6 inhibitor, in Sprague-Dawley rats and New Zealand White rabbits. Reprod Toxicol. 2019;88:76\u201384.","journal-title":"Reprod Toxicol"},{"issue":"5","key":"1619_CR24","doi-asserted-by":"publisher","first-page":"100276","DOI":"10.1016\/j.esmoop.2021.100276","volume":"6","author":"M Garutti","year":"2021","unstructured":"Garutti M, Lambertini M, Puglisi F. Checkpoint inhibitors, fertility, pregnancy, and sexual life: a systematic review. ESMO Open. 2021;6(5):100276.","journal-title":"ESMO Open"},{"key":"1619_CR25","doi-asserted-by":"publisher","first-page":"114010","DOI":"10.1016\/j.ejca.2024.114010","volume":"202","author":"H Helgadottir","year":"2024","unstructured":"Helgadottir H, Matikas A, Fernebro J, et al. Fertility and reproductive concerns related to the new generation of cancer drugs and the clinical implication for young individuals undergoing treatments for solid tumors. Eur J Cancer. 2024;202:114010.","journal-title":"Eur J Cancer"},{"key":"1619_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.exphem.2017.07.003","volume":"54","author":"S Charmsaz","year":"2017","unstructured":"Charmsaz S, Scott AM, Boyd AW. Targeted therapies in hematological malignancies using therapeutic monoclonal antibodies against Eph family receptors. Exp Hematol. 2017;54:31\u201340.","journal-title":"Exp Hematol"},{"key":"1619_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2147\/OTT.S335934","volume":"16","author":"P Mand\u00f3","year":"2023","unstructured":"Mand\u00f3 P, Waisberg F, Pasquinelli R, et al. HER2-directed therapy in advanced breast cancer: benefits and risks. Onco Targets Ther. 2023;16:115.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"1619_CR28","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/jnci\/djy094","volume":"111","author":"M Lambertini","year":"2019","unstructured":"Lambertini M, Campbell C, Bines J, et al. Adjuvant anti-HER2 therapy, treatment-related amenorrhea, and survival in premenopausal HER2-positive early breast cancer patients. J Natl Cancer Inst. 2019;111(1):86\u201394. https:\/\/doi.org\/10.1093\/jnci\/djy094.","journal-title":"J Natl Cancer Inst"},{"key":"1619_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15204923","author":"M Levi","year":"2020","unstructured":"Levi M, Goshen-Lago T, Yerushalmi R, et al. Anti-HER2\/neu antibody reduces chemotherapy-induced ovarian toxicity\u2014From bench to bedside. MDPI AG. 2020. https:\/\/doi.org\/10.3390\/cancers15204923.","journal-title":"MDPI AG"},{"key":"1619_CR30","doi-asserted-by":"crossref","unstructured":"Poorvu PD, Hu J, Zheng Y, et al. Treatment-related amenorrhea in a modern, prospective cohort study of young women with breast cancer. Springer Science and Business Media LLC. 2021","DOI":"10.1038\/s41523-021-00307-8"},{"issue":"1","key":"1619_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10549-021-06267-8","volume":"189","author":"KJ Ruddy","year":"2021","unstructured":"Ruddy KJ, Zheng Y, Tayob N, et al. Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial). Breast Cancer Res Treat. 2021;189(1):103.","journal-title":"Breast Cancer Res Treat"},{"issue":"19","key":"1619_CR32","first-page":"1994","volume":"36","author":"W Cui","year":"2021","unstructured":"Cui W, Francis PA, Loi S, et al. Assessment of ovarian function in phase III (neo)adjuvant breast cancer clinical trials: a systematic evaluation. J Clin Oncol. 2021;36(19):1994\u20132001.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1619_CR33","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s12609-020-00394-9","volume":"12","author":"S Beyer","year":"2020","unstructured":"Beyer S, Sandu A, White J. Impact and timing of breast cancer radiation therapy and fertility preservation. Curr Breast Cancer Rep. 2020;12(4):375\u201380.","journal-title":"Curr Breast Cancer Rep"},{"key":"1619_CR34","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.2147\/CMAR.S204069","volume":"11","author":"H Abdel-Razeq","year":"2019","unstructured":"Abdel-Razeq H. Gonadotropin-releasing hormone agonists during chemotherapy for ovarian function and fertility preservation for patients with early-stage breast cancer. Cancer Manag Res. 2019;11:4273\u201382.","journal-title":"Cancer Manag Res"},{"key":"1619_CR35","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/B978-0-323-47912-7.00025-1","volume-title":"Yen and Jaffe's Reproductive Endocrinology","author":"SE Bulun","year":"2019","unstructured":"Bulun SE. Endometriosis. In: Strauss JF, Barbieri RL, editors. Yen and Jaffe\u2019s Reproductive Endocrinology. 8th ed. Philadelphia: Elsevier; 2019. p. 609- 642.e7.","edition":"8"},{"issue":"9","key":"1619_CR36","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1097\/GME.0000000000002019","volume":"29","author":"Z Li","year":"2022","unstructured":"Li Z, Dong Y, Cao X, Ren S, Zhang Z. Gonadotropin-releasing hormone agonists for ovarian protection during breast cancer chemotherapy: a systematic review and meta-analysis. Menopause. 2022;29(9):1093\u2013100.","journal-title":"Menopause"},{"issue":"24","key":"1619_CR37","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1001\/jama.2015.17291","volume":"314","author":"M Lambertini","year":"2015","unstructured":"Lambertini M, Boni L, Michelotti A, et al. Ovarian suppression with triptorelin during adjuvant breast cancer chemotherapy and long-term ovarian function, pregnancies, and disease-free survival: a randomized clinical trial. JAMA. 2015;314(24):2632\u201340.","journal-title":"JAMA"},{"issue":"1","key":"1619_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5653\/cerm.2020.03594","volume":"48","author":"SY Park","year":"2021","unstructured":"Park SY, Jeong K, Cho EH, Chung HW. Controlled ovarian hyperstimulation for fertility preservation in women with breast cancer: practical issues. Clin Exp Reprod Med. 2021;48(1):1\u201310.","journal-title":"Clin Exp Reprod Med"},{"issue":"6","key":"1619_CR39","doi-asserted-by":"publisher","first-page":"e527","DOI":"10.3747\/co.25.3889","volume":"25","author":"F Cavagna","year":"2018","unstructured":"Cavagna F, Pontes A, Cavagna M, Dzik A, Donadio NF, Portela R, Nagai MT, Gebrim LH. Specific protocols of controlled ovarian stimulation for oocyte cryopreservation in breast cancer patients. Curr Oncol. 2018;25(6):e527\u201332. https:\/\/doi.org\/10.3747\/co.25.3889.","journal-title":"Curr Oncol."},{"issue":"8","key":"1619_CR40","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1007\/s43032-023-01175-2","volume":"30","author":"AS Baig","year":"2023","unstructured":"Baig AS, Camu\u00f1as NG, S\u00e1nchez PP, et al. Controlled ovarian stimulation initiated at different phases of the menstrual cycle for fertility preservation in oncological patients: a retrospective study. Reprod Sci. 2023;30(8):2547\u201353.","journal-title":"Reprod Sci"},{"issue":"6","key":"1619_CR41","doi-asserted-by":"publisher","first-page":"103367","DOI":"10.1016\/j.rbmo.2023.103367","volume":"47","author":"SD Cascante","year":"2023","unstructured":"Cascante SD, Berkeley AS, Licciardi F, McCaffrey C, Grifo JA. Planned oocyte cryopreservation: the state of the ART. Reprod Biomed Online. 2023;47(6):103367.","journal-title":"Reprod Biomed Online"},{"issue":"12","key":"1619_CR42","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/j.annonc.2020.09.006","volume":"31","author":"M Lambertini","year":"2020","unstructured":"Lambertini M, Peccatori FA, Demeestere I, et al. Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO clinical practice guidelines. Ann Oncol. 2020;31(12):1664\u201378.","journal-title":"Ann Oncol"},{"issue":"1","key":"1619_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/0974-1208.153119","volume":"8","author":"N Mahajan","year":"2015","unstructured":"Mahajan N. Fertility preservation in female cancer patients: an overview. J Hum Reprod Sci. 2015;8(1):3\u201313. https:\/\/doi.org\/10.4103\/0974-1208.153119.","journal-title":"J Hum Reprod Sci"},{"issue":"4","key":"1619_CR44","doi-asserted-by":"publisher","first-page":"hoz039","DOI":"10.1093\/hropen\/hoz039","volume":"2019","author":"E Rosenberg","year":"2019","unstructured":"Rosenberg E, Fredriksson A, Einbeigi Z, et al. No increased risk of relapse of breast cancer for women who give birth after assisted conception. Hum Reprod Open. 2019;2019(4):hoz039.","journal-title":"Hum Reprod Open"},{"issue":"5","key":"1619_CR45","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/humrep\/deac035","volume":"37","author":"L Arecco","year":"2022","unstructured":"Arecco L, Blondeaux E, Bruzzone M, et al. Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: a systematic review and meta-analysis. Hum Reprod. 2022;37(5):954\u201368.","journal-title":"Hum Reprod"},{"issue":"3","key":"1619_CR46","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/humrep\/deac249","volume":"38","author":"E Fraison","year":"2023","unstructured":"Fraison E, Huberlant S, Labrune E, et al. Live birth rate after female fertility preservation for cancer or haematopoietic stem cell transplantation: a systematic review and meta-analysis of the three main techniques; embryo, oocyte and ovarian tissue cryopreservation. Hum Reprod. 2023;38(3):489\u2013502.","journal-title":"Hum Reprod"},{"issue":"11","key":"1619_CR47","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1007\/s43032-022-00868-4","volume":"29","author":"CM Da Luz","year":"2022","unstructured":"Da Luz CM, Caetano MA, Berteli TS, et al. The impact of oocyte vitrification on offspring: a systematic review. Reprod Sci. 2022;29(11):3222\u201334.","journal-title":"Reprod Sci"},{"issue":"12","key":"1619_CR48","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1007\/s10815-023-02945-2","volume":"40","author":"MI Albamonte","year":"2023","unstructured":"Albamonte MI, Vitullo AD. Preservation of fertility in female and male prepubertal patients diagnosed with cancer. J Assist Reprod Genet. 2023;40(12):2755\u201367.","journal-title":"J Assist Reprod Genet"},{"key":"1619_CR49","doi-asserted-by":"publisher","first-page":"918899","DOI":"10.3389\/fendo.2022.918899","volume":"13","author":"AA Diaz","year":"2022","unstructured":"Diaz AA, Kubo H, Handa N, et al. A systematic review of ovarian tissue transplantation outcomes by ovarian tissue processing size for cryopreservation. Front Endocrinol. 2022;13:918899.","journal-title":"Front Endocrinol"},{"issue":"5","key":"1619_CR50","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.fertnstert.2021.03.008","volume":"115","author":"M Dolmans","year":"2021","unstructured":"Dolmans M, Von Wolff M, Poirot C, et al. Transplantation of cryopreserved ovarian tissue in a series of 285 women: a review of five leading European centers. Fertil Steril. 2021;115(5):1102\u201315.","journal-title":"Fertil Steril"},{"issue":"6","key":"1619_CR51","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.3390\/clinpract13060127","volume":"13","author":"I Boutas","year":"2023","unstructured":"Boutas I, Kontogeorgi A, Koufopoulos N, et al. Breast cancer and fertility preservation in young female patients: a systematic review of the literature. Clin Pract. 2023;13(6):1413\u201326.","journal-title":"Clin Pract"},{"issue":"1","key":"1619_CR52","doi-asserted-by":"publisher","first-page":"268.e11","DOI":"10.1016\/j.fertnstert.2009.09.046","volume":"93","author":"M S\u00e1nchez-Serrano","year":"2010","unstructured":"S\u00e1nchez-Serrano M, Crespo J, Mirabet V, et al. Twins born after transplantation of ovarian cortical tissue and oocyte vitrification. Fertil Steril. 2010;93(1):268.e11-268.e13.","journal-title":"Fertil Steril"},{"issue":"3","key":"1619_CR53","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10815-016-0843-9","volume":"34","author":"AK Jensen","year":"2017","unstructured":"Jensen AK, Macklon KT, Fedder J, et al. 86 successful births and 9 ongoing pregnancies worldwide in women transplanted with frozen-thawed ovarian tissue: focus on birth and perinatal outcome in 40 of these children. J Assist Reprod Genet. 2017;34(3):325\u201336.","journal-title":"J Assist Reprod Genet"},{"key":"1619_CR54","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/B978-0-12-822288-1.00016-6","volume-title":"Psychological and Medical Perspectives on Fertility Care and Sexual Health","author":"AR Schwartz","year":"2022","unstructured":"Schwartz AR, Moravek MB. Chapter 10 - Parenting in transgender and nonbinary individuals. In: Bergman K, Petok WD, editors. Psychological and Medical Perspectives on Fertility Care and Sexual Health. Elsevier; 2022. p. 149\u201372."},{"issue":"11","key":"1619_CR55","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s10815-013-0024-z","volume":"30","author":"J Barcroft","year":"2013","unstructured":"Barcroft J, Dayoub N, Thong KJ. Fifteen-year follow-up of embryos cryopreserved in cancer patients for fertility preservation. J Assist Reprod Genet. 2013;30(11):1407\u201313.","journal-title":"J Assist Reprod Genet"},{"issue":"22","key":"1619_CR56","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1200\/JCO.2014.59.3723","volume":"33","author":"K Oktay","year":"2015","unstructured":"Oktay K, Turan V, Bedoschi G, Pacheco FS, Moy F. Fertility preservation success subsequent to concurrent aromatase inhibitor treatment and ovarian stimulation in women with breast cancer. J Clin Oncol. 2015;33(22):2424\u20139.","journal-title":"J Clin Oncol"},{"key":"1619_CR57","first-page":"39","volume-title":"Gonadal Tissue Cryopreservation in Fertility Preservation","author":"G Bedoschi","year":"2016","unstructured":"Bedoschi G, Oktay K. Embryo cryopreservation in breast cancer patients. In: Suzuki N, Donnez J, editors. Gonadal Tissue Cryopreservation in Fertility Preservation. Tokyo: Springer Japan; 2016. p. 39\u201352."},{"issue":"3","key":"1619_CR58","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.fertnstert.2022.01.018","volume":"117","author":"KO Pomeroy","year":"2022","unstructured":"Pomeroy KO, Comizzoli P, Rushing JS, Lersten IL, Nel-Themaat L. The ART of cryopreservation and its changing landscape. Fertil Steril. 2022;117(3):469\u201376.","journal-title":"Fertil Steril"},{"issue":"4","key":"1619_CR59","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/humupd\/dmx009","volume":"23","author":"G Jones","year":"2017","unstructured":"Jones G, Hughes J, Mahmoodi N, et al. What factors hinder the decision-making process for women with cancer and contemplating fertility preservation treatment? Hum Reprod Update. 2017;23(4):433\u201357.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"1619_CR60","first-page":"52","volume":"16","author":"S Barjasteh","year":"2022","unstructured":"Barjasteh S, Farnam F, Elsous A, et al. Overcoming reproductive and psychological concerns of breast cancer survivors: a randomized controlled trial. J Fam Reprod Health. 2022;16(1):52\u201360.","journal-title":"J Fam Reprod Health"},{"issue":"5","key":"1619_CR61","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/aogs.13562","volume":"98","author":"S Logan","year":"2019","unstructured":"Logan S, Anazodo A. The psychological importance of fertility preservation counseling and support for cancer patients. Acta Obstet Gynecol Scand. 2019;98(5):583\u201397. https:\/\/doi.org\/10.1111\/aogs.13562.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"1619_CR62","doi-asserted-by":"publisher","first-page":"9645-w","DOI":"10.1038\/s41598-023-36377-w","volume":"13","author":"JKY Ko","year":"2023","unstructured":"Ko JKY, Cheung CSY, Cheng HHY, et al. Knowledge, attitudes and intention on fertility preservation among breast cancer patients. Sci Rep. 2023;13(1):9645-w.","journal-title":"Sci Rep"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-024-01619-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11912-024-01619-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-024-01619-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T06:21:35Z","timestamp":1734157295000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11912-024-01619-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":62,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1619"],"URL":"https:\/\/doi.org\/10.1007\/s11912-024-01619-1","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,27]]},"assertion":[{"value":"18 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}